Tonsillectomy for adults with recurrent streptococcal throat infection:randomised controlled trial
Tonsillectomy has some benefits
over watchful waiting. Jocalyn Clark examines a recent paper that found the
net benefit unclear and concluded that research into longer term outcomes is
needed
This month's paper
"Tonsillectomy versus watchful waiting in recurrent
streptococcal pharyngitis in adults: randomised controlled trial" by
Olli-Pekka Alho and colleagues (BMJ 2007;334:939-41, 8
March doi: 10.1136/bmj.39140.632604.55).
Abstract
Objective-To
determine the short term efficacy and safety of tonsillectomy for recurrent
streptococcal pharyngitis in adults.
Design-Randomised
controlled trial.
Setting-Academic referral
centre in Finland.
Participants-70 adults with
documented recurrent episodes of streptococcal group A pharyngitis.
Intervention-Instant
tonsillectomy (n=36) or remaining on waiting list as control
(n=34).
Main outcome measures-Percentage
change in the risk of an episode of streptococcal pharyngitis at 90 days.
Rates of all episodes of pharyngitis and days with symptoms and adverse
effects.
Results-The mean (SD)
follow-up was 164 (63) days in the control group and 170 (12) days in
the tonsillectomy group. At 90 days, streptococcal pharyngitis had recurred in
24% (8/34) in the control group and 3% (1/36) in the
tonsillectomy group (difference 21%; 95% confidence interval
6% to 36%). The number needed to undergo tonsillectomy to
prevent one recurrence was 5 (3 to 16). During the whole follow-up, the
rates of other episodes of pharyngitis and days with throat pain and fever
were significantly lower in the tonsillectomy group than in the control group.
The most common morbidity related to tonsillectomy was postoperative throat
pain (mean length 13 days, SD 4).
Conclusions-Adults with a
history of documented recurrent episodes of streptococcal pharyngitis were
less likely to have further streptococcal or other throat infections or days
with throat pain if they had their tonsils removed.
Trial registration-Clinical
Trials NCT00136877.
Some of you probably had your tonsils taken out when you were
children-especially if you were born in the '70s in the United
States, when you might have been one of millions of children who had their
tonsils removed. However, you are more likely to have been born in the
'80s, when far fewer tonsils were taken out. Nowadays there are concerns
that too many tonsillectomies are being carried out unnecessarily and without
enough information about the benefits and harms. One commentator estimates
that the rate of tonsillectomy in the United Kingdom has fallen by 34%
in the 10 years between 1994-5 and 2004-5.1
Still, it may be an appropriate procedure for some patients for whom other
treatments have failed, especially patients with recurrent tonsillitis,
estimated to be up to 12% of the population.2
This month's paper looked at whether tonsillectomy was a
good and safe treatment option in adults with recurrent streptococcal
pharyngitis.
Why do the study?
Surprisingly little evidence shows how effective tonsillectomy
might be in adults. A recent review of the evidence for the best treatments
for recurrent streptococcal throat infections published by the Cochrane
Collaboration found none that show that it is effective in adults.3
This seems important because according to Best Treatments (www.besttreatments.co.uk),
about 50000 people in the UK have their tonsils taken out a year,
half of whom are at least 15 years old.
What did the authors do?
The authors conducted a randomised controlled trial in which
patients with recurrent streptococcal pharyngitis referred to their ear, nose,
and throat clinic were assigned to receive immediate tonsillectomy or to a
waiting list for removal of their tonsils in the future. To qualify for the
trial the patients had to have had three or more episodes of streptococcal
pharyngitis in the previous six months or four episodes in the previous year.
At least one of these episodes needed to be confirmed as a group A
streptococcal infection.
Randomised controlled trials are considered the optimum
standard for testing medical treatments or surgical procedures, so it is a
good method to study the effectiveness and safety of tonsillectomy. Most
health professionals would agree that we cannot know for sure if a treatment
or procedure works and is safe until it has been studied in a randomised
controlled trial. Two main points are important. Firstly that patients are
randomly assigned to receiving the procedure of interest or not, and,
secondly, that there is a control group with which the procedure of interest
is being compared.
This randomised controlled trial is not a placebo trial, in
which the intervention (tonsillectomy in this case) would be compared with no
treatment. Instead, the authors used a "waiting list control."
This meant they assessed the patients receiving tonsillectomy immediately
without denying the other patients their needed surgery; the other patients
simply had to wait a little longer to receive it-at least 90 days in
this case.
A limitation of using a waiting list control group is that you
cannot leave them waiting too long. Therefore, the study period is often
relatively short. On the other hand, providing a waiting list helps
researchers recruit and retain patients who would otherwise not be interested
in a clinical trial in which they had a 50% chance of not receiving the
procedure being tested. In this tonsillectomy trial, patients who were
enrolled, no matter how severe their streptococcal pharyngitis pain was, knew
they would be operated on at some point.
During the study period, 298 patients were referred to the
authors' ear, nose, and throat clinic, but only 70 patients were included
in the study. Most of the excluded patients did not have recurrent
streptococcal pharyngitis, which was required for enrolment. Of the 70
patients, 36 were assigned to have their tonsils removed straight
away-this was called the tonsillectomy group. Thirty four patients were
put on the waiting list-this was the control group.
The authors recorded whether patients in both groups had any
episodes of streptococcal pharyngitis in the 90 day study period. They
determined the presence of streptococcal pharyngitis by asking patients and
confirmed this using a throat swab. They also asked all patients to keep
diaries about their symptoms and any visits to the doctor and about any
adverse effects after the surgery for the tonsillectomy patients.
What did they find?
At the end of the 90 day study period, eight patients, or
24%, in the control group and one in the tonsillectomy group
(3%) had had a streptococcal pharyngitis episode. This is a 21%
difference between groups. Based on these findings the authors calculated a
measure called "number needed to treat" (NNT), which can be a
helpful way of understanding how effective a treatment is. They reported an
NNT of five. This means that five people had to have a tonsillectomy for one
of them to avoid a streptococcal pharyngitis episode within three months.
In addition to looking at the differences in the percentage of
patients in each group who got streptococcal pharyngitis in those 90 days, the
authors also compared the time it took to have a streptococcal pharyngitis
episode among those who did. They found that the times to first episode of
streptococcal pharyngitis in the control group were much shorter that of the
tonsillectomy group.
When it comes to studying how good medical treatments or
surgical procedures are, we must also look at whether they have any harms. The
authors assessed the adverse effects that the tonsillectomy had. They report
that for most patients the tonsil removal operation took one hour; needed to
stay one day in hospital; and on average needed 13 days' recovery at
home, which involved throat pain. The authors do not report how severe this
throat pain was. Among the patients who got tonsillectomy in this study, there
were no severe consequences of the surgery. However, two patients (6%)
had mild secondary bleeding.
What does the study mean?
The study is important because it is one of few trials that
has considered tonsillectomy in adults. The authors conclude that their study
supports removal of the tonsils to prevent immediate additional episodes of
streptococcal pharyngitis in adults with a history of recurrent streptococcal
pharyngitis. They also conclude that tonsillectomy is not only effective but
also safe.
The study has several limitations that are important, many of
which pointed out by Paul Little in the editorial accompanying the paper in
BMJ and in the rapid responses published on bmj.com.45
As mentioned above, this study was only able to tell us about streptococcal
pharyngitis episodes in a short 90 day follow-up period, and we
don't know from this study if removal of the tonsils has a longer effect
on preventing streptococcal pharyngitis episodes. For many patients, having to
endure a 13 day recovery period with throat pain may not be worth the chance
that they have fewer streptococcal pharyngitis episodes in 90 days.
This trial is a step forward on a path that is not yet well
paved. We need more evidence about the effectiveness and safety of
tonsillectomy, and this study offers a good start. Until more studies provide
longer term and more safety data, however, it is difficult to give sound
advice to doctors and patients.
Jocalyn Clark, associate editor, BMJ
Email: jclark@bmj.com
Competing
interests: None declared.
studentBMJ 2007;15:213-256 June ISSN 0966-6494
- Hospital
Episode Statistics. Trends in ENT admission rates. London: Department of
Health. www.hesonline.nhs.uk/
Ease/servlet/ContentServer?siteID=1937&categoryID=410
- Kvestad E, Kvaerner K,
Roysamb E, Tambs K, Harris J, Magnus P. Heritability of recurrent tonsillitis. Arch
Otolaryngol Head Neck Surg 2005;131:383-7.
- Burton MJ, Towler B,
Glasziou P. Tonsillectomy versus non-surgical treatment for
chronic/recurrent acute tonsillitis. Cochrane Database Syst Rev
2000;(2):CD001802.
- Little P. Recurrent
pharyngo-tonsillitis. BMJ 2007;334:909. doi: 10.1136/bmj.39184.617049.80.
- Electronic responses.
Tonsillectomy versus watchful waiting in recurrent streptococcal pharyngitis
in adults: randomised controlled trial. BMJ 2007. www.bmj.com/cgi/eletters/334/7600/909